These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 845449)

  • 1. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG; Shuster S; Thody AJ; Peberdy M
    J Invest Dermatol; 1977 Apr; 68(4):169-70. PubMed ID: 845449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure.
    Smith AG; Shuster S; Bomford A; Williams R
    J Invest Dermatol; 1978 Jun; 70(6):326-7. PubMed ID: 649979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloasma and oral contraceptives.
    Carruthers R
    Med J Aust; 1966 Jul; 2(1):17-20. PubMed ID: 5944123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phlebitis and chloasma in patient taking oral contraceptives].
    Merklen FP; Cottenot F; Potier JC
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(6):801-3. PubMed ID: 5590531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Patients treated for gynecologic cancer after use of oral contraceptives and IUD].
    Szegvári M; Altmayer P
    Orv Hetil; 1979 Apr; 120(13):756-8. PubMed ID: 424201
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
    Kew MC; Mzamane D; Smith AG; Shuster S
    Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
    [No Abstract]   [Full Text] [Related]  

  • 7. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure.
    Smith AG; Shuster S; Comaish JS; Plummer NA; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1975 Mar; 1(5959):658-9. PubMed ID: 1125653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endocrinologic principles of pigmentation disorders due to contraceptives].
    Leonhardi G
    Arch Dermatol Forsch; 1972; 244():495-9. PubMed ID: 4648759
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma ACTH and melanocyte-stimulating hormone in nail pigmentation.
    Arakawa S; Takamatsu T; Imashuku S; Kusunoki T
    Arch Dis Child; 1978 Mar; 53(3):249-50. PubMed ID: 206211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fertility disorders after taking contraceptive tablets].
    Godó G; Koloszár S; Sas M
    Orv Hetil; 1984 Feb; 125(6):313-6. PubMed ID: 6694848
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W
    Wiad Lek; 1983 Oct; 36(19):1587-92. PubMed ID: 6198806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncompetitive enzyme immunoassay (hetero-two-site enzyme immunoassay) for gamma 2-melanocyte-stimulating hormone (gamma 2-MSH) and measurement of immunoreactive gamma 2-MSH in plasma of healthy subjects.
    Yogi Y; Hashida S; Ekman R; Setoguchi T; Ishikawa E
    J Clin Lab Anal; 1995; 9(6):397-406. PubMed ID: 8587009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of pigmentation disorders due to oral contraceptives].
    Ippen H
    Arch Dermatol Forsch; 1972; 244():500-3. PubMed ID: 4648760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pituitary hormones (beta MSH-ACTH) in hyperpigmented hepatic cirrhosis. Apropos of 10 cases].
    Valla D; Cunci O; Girard F; Thomas M
    Med Chir Dig; 1976; 5(7):329-34. PubMed ID: 190485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma ACTH and beta-MSH in normal subjects and in pituitary-adrenal pathology and in non-endocrine pigmentation disorders].
    Usategui Echevarría R; Oliver C; Laffite JM; Jimeno Carruez A; Ortíz Manchado O; Vague J
    Rev Clin Esp; 1975 Oct; 139(2):163-9. PubMed ID: 172985
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma immunoreactive beta-melanocyte stimulating hormone (lipotropin) levels in individuals with Prader-Labhart-Willi syndrome.
    Butler MG; Jenkins BB; Orth DN
    Am J Med Genet; 1987 Dec; 28(4):839-44. PubMed ID: 3688022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
    Raps M; Curvers J; Helmerhorst FM; Ballieux BE; Rosing J; Thomassen S; Rosendaal FR; van Vliet HA
    Thromb Res; 2014 Apr; 133(4):640-4. PubMed ID: 24438944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chloasma uterinum due to contraceptive agents].
    Ippen H
    Hautarzt; 1972 May; 23(5):235. PubMed ID: 5043827
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloasma and the contraceptive pill.
    Quamina DB
    Br Med J; 1967 Jun; 2(5552):638. PubMed ID: 6025608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.